SCHEMBL8002989

SCHEMBL8002989

Nc1cc([N+](=O)[O-])c([N+](=O)[O-])cc1Br

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
CYP3A4 P08684 4/20 0.53
CTSB P07858 1/20 0.52
TDP1 Q9NUW8 5/20 0.47
MAPT P10636 3/20 0.47
TSHR P16473 2/20 0.47
MEN1 O00255 2/20 0.47
POLB P06746 2/20 0.47
KMT2A Q03164 2/20 0.47
ALOX15 P16050 1/20 0.47
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
GPR35 Q9HC97 1/20 0.42
MCL1 Q07820 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3718211 0.89 ALDH1A1 (0.52) ALDH1A1CYP3A4CTSBTDP1MAPT
SCHEMBL13609636 0.89 ALDH1A1 (0.52) ALDH1A1CYP3A4CTSBTDP1MAPT
Bromide SCHEMBL4266547 0.87 ALDH1A1 (0.50) ALDH1A1CYP3A4CTSBTDP1MAPT
SCHEMBL11550471 0.84 ALDH1A1 (0.52) ALDH1A1CYP3A4CTSBTDP1MAPT
SCHEMBL431211 0.84 ALDH1A1 (0.47) ALDH1A1CYP3A4CTSBTDP1MAPT
SCHEMBL351739 0.84 ALDH1A1 (0.47) ALDH1A1CYP3A4CTSBTDP1MAPT
SCHEMBL2800695 0.84 CYP3A4 (0.52) ALDH1A1CYP3A4CTSBTDP1MAPT
SCHEMBL2249179 0.83 ALDH1A1 (0.52) ALDH1A1CYP3A4CTSBTDP1MAPT
SCHEMBL1258484 0.83 CYP3A4 (0.56) ALDH1A1CYP3A4TDP1MAPTTSHR
SCHEMBL30393904 0.83 CYP3A4 (0.56) ALDH1A1CYP3A4TDP1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6136779-A CONTACTING A CELL WHICH IS CAPABLE OF EXPRESSING THE GENE WITH AN AMOUNT OF A MOLECULE EFFECTIVE TO TRANSCRIPTIONALLY MODULATE EXPRESSION OF THE GENE AND THEREBY AFFECT THE LEVEL OF THE PROTEIN ENCODED BY THE GENE WHICH IS EXPRESSED BY THE OSI PHARMACEUTICALS, INC. (US) 2000-10-24 US disclosed